Back to Rare Disease
NCT05643274
NCT05643274
Who may be able to join
Who might be able to join this trial:
- You are a child or adult who has been identified as having developmental or neurological difficulties, and doctors strongly suspect you have a rare genetic condition (either running in the family or appearing severely for the first time).
- Previous genetic testing using a standard method (called "short read sequencing") on you and both of your parents did not find an explanation for your condition.
- You (or your legal guardian, if you are a minor or under legal protection) have agreed to take part by signing a consent form.
- You are covered by the French national health insurance system (Sécurité Sociale).
- For parents taking part: both parents are available and eligible to join, have signed their own consent forms, and are also covered by French national health insurance.
Who may not be able to join:
- A genetic cause for your condition has already been found.
- The full genome test (called "whole genome sequencing") has not yet been done on you and both of your parents.
- You have previously withdrawn your agreement to take part in the study.
- For parents: a mother who is currently pregnant or breastfeeding cannot take part.
- For parents: parents who are themselves under legal guardianship or court protection cannot take part.
- For parents: parents who also have developmental or neurological difficulties themselves cannot take part.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Nantes University Hospital
Registry
clinicaltrials_gov
Start date
19 December 2022
Est. completion
8 March 2023
Where this trial is recruiting
🇫🇷 France
Primary endpoints
Use of long read sequencing in patients suffering from a neurodevelopmental disease without pathogenic or probably pathogenic variation identified by short read sequencing
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.